Bengaluru-based Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd has announced that the Board of Directors of Biocon Biologics have appointed Kedar Upadhye as the new Chief Financial Officer (CFO) and the company’s current CFO, MB Chinappa, will transition to take on a strategic finance role at Biocon Group. These leadership changes will be effective October 31, 2023.

Upadhye brings with him over 23 years of experience in senior global leadership roles spanning Corporate Finance, Strategy, Accounting, FP&A, Business Finance, Governance and Investor Relations at leading Pharma, Energy and FMCG players such as Cipla, Dr. Reddy’s, PepsiCo, and Thermax.

He joins us from ReNew Energy Global Plc, a NASDAQ-listed decarbonization & renewable energy company, where he was the Chief Financial Officer (CFO). Prior to ReNew, Kedar was the Global CFO at Cipla where he was instrumental in setting up a strong global finance footprint with a focus on capital allocation, strategic partnership with the business, governance, and risk management in addition to driving the organisation towards the next level of growth and delivering a superior return profile. He has a proven track record of overseeing value creation, strengthening investor relations and acting as an enabler of business.